文献速递生殖医学

经超声诊断的子宫内膜异位症与接受首次体外受精/卵胞浆内单精子注射治疗女性较低的活产率相关

Endometriosis diagnosed by ultrasound is associated with lower live birth rates in women undergoing their first in vitro fertilization/intracytoplasmic sperm injection treatment.
PubMed 文献 · Fertil Steril · 2024-01-19

前瞻性观察性队列研究纳入1040例子宫内膜异位症不孕女性,首次IVF/ICSI前经阴道超声按IDEA标准诊断深部浸润型子宫内膜异位症(DIE)和/或子宫内膜瘤者234例(22.5%)。总累积活产率41.0%,DIE和/或子宫内膜瘤组33.3%低于无病组43.2%,校正后RR 0.63(95%CI 0.48-0.82)。

要点

  • 首次IVF/ICSI前经阴道超声诊断DIE和/或子宫内膜瘤者累积活产率低于无病者。
  • 两组获成熟卵母细胞数、受精率及优质胚胎数无差异。
  • 校正年龄、BMI、AMH、刺激方案及移植日后,DIE和/或子宫内膜瘤与活产降低相关。

核心结论

  • 经阴道超声诊断的DIE和/或子宫内膜瘤会降低首次IVF/ICSI治疗女性的活产机会。

研究设计与样本

  • 前瞻性观察性队列研究,在大学医院进行,纳入2019年1月至2022年10月间接受首次IVF/ICSI治疗的1040例25至≤39岁不孕女性。
  • 其中234例(22.5%;95%CI 20.0-25.0)在开始治疗前经系统经阴道超声诊断DIE和/或子宫内膜瘤。
  • 所有女性接受首次IVF或ICSI治疗,使用第一周期的新鲜和/或冷冻胚胎直至妊娠或无可移植胚胎。

主要发现

  • 总队列首次IVF/ICSI后累积活产率为426/1040(41.0%;95%CI 38.0-44.0)。
  • DIE和/或子宫内膜瘤组累积活产率为78/234(33.3%;95%CI 27.3-39.4),低于无病组的348/806(43.2%;95%CI 39.8-46.6)。
  • DIE和/或子宫内膜瘤组累积活产的粗相对风险(RR)为0.77(95%CI 0.63-0.94),校正年龄、体质指数、抗苗勒管激素、刺激方案及胚胎移植日后校正RR为0.63(95%CI 0.48-0.82)。
  • 两组间获成熟卵母细胞数、受精率及优质胚胎数无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study the cumulative live birth rate (CLBR) after the first in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) treatment in women with or without deep-infiltrating endometriosis (DIE) and/or endometrioma diagnosed by transvaginal ultrasonography (TVUS), using the International Deep Endometriosis Analysis (IDEA) group definitions. DESIGN: Prospective observational cohort study at a university hospital. PATIENTS(S): In total, 1,040 women with subfertility aged 25 to ≤39 years were undergoing their first IVF/ICSI treatment between January 2019 and October 2022. Of these, 234 (22.5%; 95% confidence interval [CI], 20.0-25.0) women were diagnosed with DIE and/or endometrioma at systematic TVUS before starting their treatment. INTERVENTION(S): All women underwent their first IVF or ICSI treatment. Fresh and/or frozen embryos from the first cycle were used until pregnancy was achieved or no embryos remained. MAIN OUTCOME MEASURE(S): Cumulative live birth rate after the first IVF/ICSI cycle in women with or without DIE and/or endometrioma. RESULT(S): The CLBR after the first IVF/ICSI treatment in the total cohort of women was 426/1,040 (41.0%; 95% CI, 38.0-44.0). Women with DIE and/or endometrioma had a lower CLBR (78/234, 33.3%; 95% CI, 27.3-39.4) than women without the disease (348/806, 43.2%; 95% CI, 39.8-46.6). The crude relative risk (RR) for cumulative live birth for women with DIE and/or endometrioma was 0.77; 95% CI, 0.63-0.94, and after adjustments were made for age, body mass index, s-antimüllerian hormone, stimulation protocol, and day for embryo transfer, the adjusted RR was 0.63; 95% CI, 0.48-0.82. There was no difference in the number of retrieved mature oocytes, fertilization rate, or good quality embryos between the 2 groups. CONCLUSION: The presence of DIE and/or endometrioma diagnosed by TVUS lowers the chance of live birth in women undergoing their first IVF/ICSI treatment.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Alson S, Henic E, Jokubkiene L, et al. Endometriosis diagnosed by ultrasound is associated with lower live birth rates in women undergoing their first in vitro fertilization/intracytoplasmic sperm injection treatment. Fertil Steril. 2024. PMID: 38246403. doi:10.1016/j.fertnstert.2024.01.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。